---
title: "2302P Efficacy assessment of targeted and immunotherapies for personalised treatment of melanoma using 2D and 3D ex-vivo assays"
authors:
  - admin
  - Greg Wells
  - Juha Rantala
  - Thomas Helleday
  - Munitta Muthana
  - Sarah Danson
date: "2023-10-20T00:00:00Z"
doi: "10.1016/j.annonc.2023.09.2176"

publishDate: "2023-10-20T00:00:00Z"

publication_types: ["paper-conference"]

publication: "*Annals of Oncology*, 34(Suppl 2):S1177 — European Society for Medical Oncology (ESMO) Congress 2023, Madrid, Spain"
publication_short: "*Ann Oncol* (ESMO 2023)"

abstract: "We present an ex vivo drug efficacy assessment platform for personalized melanoma treatment, evaluating targeted therapies and immunotherapies using 2D monolayer and 3D organoid culture models. High-content imaging and functional screening were applied to patient-derived biosamples to predict individual drug response."

summary: "Conference abstract presenting an ex vivo platform for personalised melanoma treatment using 2D/3D culture models and high-content drug screening at ESMO Congress 2023."

tags:
  - Oncology
  - Melanoma
  - Drug Screening
  - Ex Vivo
  - Conference

featured: true

links:
  - name: Abstract
    url: https://www.annalsofoncology.org/article/S0923-7534(23)02166-X/fulltext
url_pdf: ''
url_code: ''
url_dataset: ''
url_poster: ''
url_project: 'project/evident-cancer-screening'
url_slides: ''
url_source: ''
url_video: ''

image:
  caption: 'ESMO Congress 2023, Madrid — Poster Presentation'
  focal_point: "Smart"
  preview_only: false

projects:
  - evident-cancer-screening
---
